Skip to main content

Table 3 Pregnant women group baseline characteristics of included studies

From: Toxoplasmosis seroprevalence in Iranian women and risk factors of the disease: a systematic review and meta-analysis

Province

Total individuals

IgG-positive cases (%)

IgM-positive cases (%)

IgG- and IgM-positive cases (%)

Total prevalence (%)

Authors

Kermanshah

495

162(32.72)

  

162(32.72)

Athari et al., 1994

Mazandaran

612

435(71.07)

  

435(71.07)

Saffar et al., 1999

Isfahan

317

98(30.91)

4(1.26)

 

102(32.17)

Talari et al., 2001

Isfahan

340

207(60.88)

  

207(60.88)

Arbabi et al., 2002

Tehran

4120

2804(68.05)

  

2804(68.05)

Gharavi et al., 2002

Tehran

140

48(34.28)

10(7.14)

 

58(41.42)

Noorbakhsh et al., 2002

Isfahan

270

72(26.66)

15(5.55)

 

87(32.22)

Talari et al., 2003

Hormozgan

418

143(34.21)

33(7.89)

10(2.39)

186(44.49)

SotoudehJahromi et al., 2003

Qom

600

257(42.83)

  

257(42.83)

Mardani et al., 2003

Sistan and Baluchestan

200

54(27)

  

54(27)

Sharifi Mood et al., 2004

Chaharmahal and Bakhtiari

384

106(27.60)

  

106(27.60)

Manuchehri et al., 2007

Khuzestan

79

28(35.44)

  

28(35.44)

Sohrabi et al., 2007

Ilam

553

247(44.66)

  

247(44.66)

Abdi et al., 2008

Hamedan

576

193(33.50)

  

193(33.50)

Fallah et al., 2008

Qazvin

255

160(62.74)

  

160(62.74)

Eskandarian et al., 2009

Kurdistan

201

54(26.86)

24(11.94)

33(16.41)

111(55.22)

Parvizpour et al., 2010

Lorestan

390

121(31.02)

29(7.43)

 

150(38.46)

Cheraghi Pour et al., 2010

Lorestan

331

130(39.27)

35(10.57)

 

165(49.84)

Cheraghi Pour et al., 2010

Isfahan

127

67(52.75)

  

67(52.75)

Ghasemi et al., 2011

Zanjan

500

186(37.2)

7(1.4)

 

193(38.60)

Hajsoleimani et al., 2012

Hormozgan

608

252(41.44)

  

252(41.44)

JamshidiMakiani et al., 2012

East Azerbaijan

300

79(26.33)

1(0.33)

 

80(26.66)

DalimiAsl et al., 2012

Mazandaran

1057

739(69.91)

57(5.39)

 

796(75.30)

SiyadatPanah et al., 2013

Qom

200

76(38)

11(5.5)

 

87(43.50)

Akhlaghi et al., 2013

Razavi Khorasan

419

144(34.36)

 

27(18.75)a

171(40.81)

Babaie et al., 2013

Hamedan

350

105(30)

 

3(2.85)b

108(30.85)

Maghsood et al., 2013

Sistan and Baluchestan

221

68(30.76)

3(1.35)

3(1.35)

74(33.48)

Ebrahimzadeh et al., 2013

Lorestan

496

154(31.04)

 

35(22.72)c

189(38.10)

RostamiNejad et al., 2013

Qom

400

145(36.25)

21(5.25)

 

166(41.50)

Maleki et al., 2013

Markazi

308

117(37.98)

 

3(1.74)d

120(38.96)

Vakil et al., 2014

Mazandaran

289

170(58.82)

7(2.42)

4(1.38)

181(62.62)

Hoseini et al., 2014

Sistan and Baluchestan

185

19(10.27)

1(0.54)

1(0.54)

21(11.35)

Mousavi et al., 2014

Mazandaran

175

106(60.57)

  

106(60.57)

Kalantari et al., 2014

Golestan

555

221(39.81)

19(3.42)

8(1.44)

248(44.68)

Sharbatkhori et al., 2014

Khuzestan

501

137(27.34)

7(1.39)

3(0.59)

147(29.34)

Yadyad et al., 2014

Tehran

785

244(31.08)

  

244(31.08)

Ghasemloo et al., 2014

East Azerbaijan

195

115(58.97)

  

115(58.97)

Haji SeidJavadi et al., 2014

Mazandaran

50

26(52)

  

26(52)

ElahianFirouz et al., 2014

Yazd

181

58(32.04)

  

58(32.04)

Anvari et al., 2014

Alborz

400

116(29)

4(1)

 

120(30)

Akhlaghi et al., 2014

Isfahan

798

341(42.73)

5(0.62)

 

346(43.35)

Rasti et al., 2015

Qazvin

200

58(29)

4(2)

 

62(31)

Tabatabaieet al., 2015

East Azerbaijan

391

267(68.28)

  

267(68.28)

Rajaii et al., 2015

Hamedan

2523

681(26.99)

51(2.02)

 

732(29.01)

Hamidi et al., 2015

Khuzestan

110

47(42.72)

3(2.72)

 

50(45.45)

Saki et al., 2016

  1. aTotal individuals for IgM seropositivity is 144
  2. bTotal individuals for IgM seropositivity is 105
  3. cTotal individuals for IgM seropositivity is 154
  4. dTotal individuals for IgM seropositivity is 172